Date and time
Start: Thursday 26 March 2020, 12:30 PM
End: Thursday 26 March 2020, 01:30 PM
Thursday 26 March
Start: Thursday 26 March 2020, 12:30 PM
End: Thursday 26 March 2020, 01:30 PM
This webinar presented by Duncan Curley will provide an update on the recent caselaw on SPCs: the end of the Truvada (Gilead v Teva and others) saga; the CJEU decisions of 2019 reviewed; discussion of the latest references; some thoughts on the SPC manufacturing waiver and finally, some speculation about what the future holds for SPCs in the UK, having “taken back control”.
Fellows, Students
Dr Duncan Curley qualified as a solicitor in 1995. He subsequently became a partner in the intellectual property department of an international law firm and then founded a boutique IP legal practice that he ran for 15 years. Duncan joined Penningtons Manches Cooper as a partner in 2022. The firm acts for multinational and UK-based generic pharmaceutical companies on regulatory, patent and trademark issues, including freedom to operate, patent clearance and litigation. Duncan is the author of numerous published articles on IP and regulatory issues, including the chapter on patents and regulatory data exclusivity for medicinal products in the recently published second edition of the OUP textbook “Overlapping Intellectual Property Rights”.
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here